Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
Ranbaxy Laboratories has decided to separate the two areas of research and development - drug discovery and generics/NDDS/drug development - to achieve increased focus and rigour for success.
The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.